Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
ZielBio
AddedFeb 17, 2024
UpdatedJun 18, 2026
ZielBio

ZielBio

Series A

ZielBio: An early-stage biotech firm innovating patient outcomes through novel drug discovery.

HQ
Charlottesville, VA, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

Founded as an early-stage biotechnology company, ZielBio focuses on identifying novel high-value disease targets and developing therapeutic interventions to improve patient outcomes. The company's core mission is to reimagine drug discovery through its proprietary platform, Zielfind, which combines functional, high-throughput screening with large content data analysis. ZielBio aims to develop new therapeutic modalities that can significantly impact how diseases are treated, ultimately enhancing the quality of life for patients.

ZielBio has attracted notable investors and industry experts who support its innovative approach to drug discovery. The company has achieved key milestones in identifying druggable and specific targets that hold the potential to revolutionize disease treatment. Through its groundbreaking technology and dedicated research, ZielBio has made a significant impact in the biotechnology sector, positioning itself as a leader in the development of novel therapies aimed at improving patient outcomes.

ZielBio - Similar Companies

Unravel Biosciences logo

Unravel Biosciences

unravel.bio

Pepper Bio logo

Pepper Bio

pepper.bio

BridGene Biosciences logo

BridGene Biosciences

Curie.Bio logo

Curie.Bio

curie.bio

Triana Biomedicines logo

Triana Biomedicines

trianabio.com

TigerGene logo

TigerGene

Rezo Therapeutics logo

Rezo Therapeutics

rezotx.com

Reactive Biosciences logo

Reactive Biosciences

reactivebio.com

Actio Biosciences logo

Actio Biosciences

actiobio.com

Algen Biotechnologies logo

Algen Biotechnologies

algenbio.com

Design Pharmaceuticals logo

Design Pharmaceuticals

BlueLight Therapeutics logo

BlueLight Therapeutics

bluelighttx.com

Greenstone Biosciences logo

Greenstone Biosciences

Zephyr AI logo

Zephyr AI

zephyrai.bio

Flexomics logo

Flexomics

flexomics.com

ZielBio - Quick Facts

Who are ZielBio's competitors?

Companies similar to ZielBio include Unravel Biosciences, Pepper Bio, BridGene Biosciences and Curie.Bio.

When was ZielBio founded?

ZielBio was founded in 2011.

Where is ZielBio's headquarters located?

ZielBio's headquarters is located in Charlottesville, VA, US.

When was ZielBio's last funding round?

ZielBio's most recent funding round was for $7.5M (USD) in September 2022.

How much has ZielBio raised to-date?

As of Sep 27, 2022, ZielBio has raised a total of $33M (USD).

How many employees does ZielBio have?

ZielBio has 13 employees as of Feb 5, 2024.

ZielBio - Classification

Ownership
  • Private Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Discovery
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified